| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |